A common heart medication may contain a cancer-causing chemical, the FDA said. The U.S. Food and Drug Administration (FDA) is expanding a recall of a common heart medication because it may contain a ...
(HealthDay News) — For patients with impaired glucose tolerance (IGT), valsartan is associated with reduced incidence of microalbuminuria, according to a study published online in Diabetes, Obesity ...
Researchers have found in a new study that in non-diabetic patients with advanced chronic kidney disease, combined therapy ...
Sacubitril/valsartan significantly reduces NT-proBNP levels in patients with heart failure with reduced ejection fraction (HFrEF) over 3 years, with no significant changes in sST2 and galectin-3.
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using SACUBITRIL/VALSARTAN ALPHAPHARM?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback